![Geoffrey E. Clark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Geoffrey E.
Clark is currently the Chairman at Ischemix, Inc. He was formerly the Chief Medical Officer at Citius Pharmaceuticals, Inc.
Cargos activos de Geoffrey E. Clark
Empresas | Cargo | Inicio |
---|---|---|
Ischemix, Inc.
![]() Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Presidente | - |
Antiguos cargos conocidos de Geoffrey E. Clark.
Empresas | Cargo | Fin |
---|---|---|
CITIUS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 12/09/2014 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CITIUS PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Ischemix, Inc.
![]() Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Health Technology |
- Bolsa de valores
- Insiders
- Geoffrey E. Clark